‘The bar has risen’: China’s biotech gains push US companies to adapt
BioPharma Drive: Drug Pricing
JANUARY 16, 2025
Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive at the J.P. Morgan Healthcare Conference.
Let's personalize your content